This inventor holds 1 USPTO granted patent. Top assignee: Medicis Pharmaceutical Corporation. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Michael H Gold: Innovator in Dermatological Treatments
Introduction
Michael H Gold is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of dermatology, particularly in the treatment of actinic keratosis. His innovative approach combines established therapies to enhance patient outcomes.
Latest Patents
Michael H Gold holds a patent for a groundbreaking method titled "Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis." This patent focuses on the use of sequentially applied topical therapy with a lower dosage strength imiquimod composition, followed by photodynamic therapy. The method aims to improve the effectiveness of treatment for actinic keratosis, a common skin condition caused by sun exposure. The imiquimod composition in this therapy typically contains between 1% (w/w) and 4.25% (w/w) imiquimod.
Career Highlights
Gold is associated with Medicis Pharmaceutical Corporation, where he has contributed to the development of innovative dermatological treatments. His work has been instrumental in advancing therapeutic options for patients suffering from skin conditions.
Collaborations
Michael H Gold has collaborated with esteemed colleagues such as Tze-Chiang Meng and Girish S Munavalli. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in dermatological research.
Conclusion
Michael H Gold's contributions to dermatology through his innovative patent demonstrate his commitment to improving patient care. His work exemplifies the importance of combining therapies to achieve better treatment outcomes.